
Capital Raising & Corporate Finance
Eli Lilly Issues Rare 40-Year Bond
Eli Lilly is making waves in the corporate debt market with a $6.75 billion multi-tranche bond sale that includes a rare 40-year note: an unusual move for a pharmaceutical company. Most corporate bonds mature in five to 30 years.